# Xiaoyao San ameliorates maternal inflammation-induced neurobehavioral deficits by modulating the microbiota-gut-brain axis in offspring

**Authors:** Chunqiao Lin, Jiushuang Zhu, Lu Zhang, Lijie Shi, Zhuoting Zhong, Xiuwen Xia, Weijun Ding, Youjun Yang

PMC · DOI: 10.3389/fphar.2025.1563496 · Frontiers in Pharmacology · 2025-05-19

## TL;DR

Xiaoyao San improves neurobehavioral issues in offspring caused by maternal inflammation by affecting gut microbes and brain chemistry.

## Contribution

Xiaoyao San is shown to modulate the gut-brain axis and restore neurotransmitter balance in maternal inflammation-induced neurobehavioral deficits.

## Key findings

- Xiaoyao San improves social interaction and reduces repetitive behaviors in offspring of inflamed mothers.
- Xiaoyao San restores cerebral glutamate-GABA balance via the glutamine pathway.
- Bacteroides spp., especially B. uniformis, mediate Xiaoyao San's neurophysiological effects through metabolic regulation.

## Abstract

XiaoYao San (XYS), a classical Traditional Chinese Medicine (TCM), has demonstrated efficacy in alleviating stress-related neuropsychiatric disorders. However, its therapeutic potential against maternal immune activation (MIA)-induced neurobehavioral impairments remains unexplored. This study aims to investigate the neuroprotective effects of XYS on MIA-related behavioral dysfunctions and elucidate its underlying mechanisms.

Using a poly (I:C)-induced MIA mouse model, we demonstrated that XYS effectively ameliorates autism spectrum disorder (ASD) related behavioral phenotypes. Mechanistic investigations revealed that XYS exerts its therapeutic effects through: (1) Attenuation of core behavioral deficits including enhanced social interaction and reduced repetitive behaviors; (2) Downregulation of intestinal amino acid transporters; (3) Restoration of cerebral glutamate-GABA balance via modulation of glutamine pathway; (4) Structural remodeling of gut microbiota with specific enrichment of Bacteroides spp. Notably, B. uniformis was identified as a key microbial mediator capable of recapitulating XYS-mediated neurophysiological improvements through metabolic regulation.

This study elucidates XYS as a multi-target therapeutic agent that coordinately modulates gut microbial ecosystems, amino acid homeostasis, and neurotransmitter homeostasis. The findings provide novel insights into the gut-brain axis mechanisms of TCM formulations, offering a scientific foundation for developing microbiota-based intervention strategies for neurodevelopmental disorders.

## Linked entities

- **Diseases:** autism spectrum disorder (MONDO:0005258)

## Full-text entities

- **Diseases:** behavioral dysfunctions (MESH:D001523), behavioral deficits (MESH:D019958), neurobehavioral deficits (MESH:D019954), neurodevelopmental disorders (MESH:D002658), ASD (MESH:D000067877), inflammation (MESH:D007249)
- **Chemicals:** poly (I:C) (MESH:D011070), glutamate (MESH:D018698), glutamine (MESH:D005973), GABA (MESH:D005680)
- **Species:** Bacteroides uniformis (species) [taxon 820], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12127538/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12127538/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12127538/full.md

---
Source: https://tomesphere.com/paper/PMC12127538